161 related articles for article (PubMed ID: 2013119)
1. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
2. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin chemotherapy in patients with recurrent high-grade glioma.
Murray LJ; Bridgewater CH; Levy D
Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):55-61. PubMed ID: 20952169
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
[TBL] [Abstract][Full Text] [Related]
5. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
[TBL] [Abstract][Full Text] [Related]
7. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
[TBL] [Abstract][Full Text] [Related]
9. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.
Roci E; Cakani B; Brace G; Bushati T; Rroji A; Petrela M; Kaloshi G
Med Arch; 2014; 68(2):140-3. PubMed ID: 24937942
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Poisson M; Péréon Y; Chiras J; Delattre JY
J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin chemotherapy in patients with recurrent high-grade glioma.
Kaloshi G; Petrela M
Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):495. PubMed ID: 21459563
[No Abstract] [Full Text] [Related]
12. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of carboplatin or iproplatin in cervical cancer.
Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group.
van Wijk FH; Lhommé C; Bolis G; Scotto di Palumbo V; Tumolo S; Nooij M; de Oliveira CF; Vermorken JB;
Eur J Cancer; 2003 Jan; 39(1):78-85. PubMed ID: 12504662
[TBL] [Abstract][Full Text] [Related]
16. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of carboplatin in children with progressive low-grade gliomas.
Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
[TBL] [Abstract][Full Text] [Related]
18. Toxicities of the platinum antineoplastic agents.
Markman M
Expert Opin Drug Saf; 2003 Nov; 2(6):597-607. PubMed ID: 14585068
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of iproplatin in advanced ovarian carcinoma.
Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
